Expanding postmortem donor pool using steatotic liver grafts: A new look

Transplantation

Volumn 87, Issue 6, 2009, Pages 919-925

  Noujaim, Huda M ^a,e   De Ville De Goyet, Jean ^b   Montero, Edna F S ^c   Ribeiro, Cristiane M F ^a   Capellozzi, Vera L ^d   Crescentini, Fabio ^a   Casagrande, Matheo ^a   Santos, Regina G ^a   Curvello, Lillian ^a   De Miranda, Marcelo P ^a   Genzini, Tercio ^a  

^a HOSPITAL BENEFICÊNCIA PORTUGUESA DE SÃO PAULO   (Brazil)

^b BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

^e Rua Maestro Cardim 769   (Brazil)

Author keywords

Donor pool; Hepatic steatosis; Liver transplant; Marginal donors; Outcome

Indexed keywords

ARTICLE; CADAVER; CADAVER DONOR; FATTY LIVER; GRAFT DYSFUNCTION; GRAFT SURVIVAL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER FUNCTION; LIVER GRAFT; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK ASSESSMENT; SURVIVAL; ADULT; BIOPSY; BLOOD; CAUSE OF DEATH; CLASSIFICATION; DONOR; FEMALE; LIVER FAILURE; LIVER FUNCTION TEST; MALE; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; STATISTICS; TRANSPLANTATION;

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; SODIUM;

ADULT; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; BIOPSY; CADAVER; CAUSE OF DEATH; FATTY LIVER; FEMALE; HUMANS; LIVER FAILURE; LIVER FUNCTION TESTS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SODIUM; TISSUE AND ORGAN HARVESTING; TISSUE DONORS;

EID: 65549091908     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31819b3f76     Document Type: Article

References (37)

1. Neuberger J. Liver transplantation. J Hepatol 2000; 32(suppl 1): 198.
2. Strong RW. Liver transplantation: Current status and future prospects. J R Coll Surg Edinb 2001; 46: 1.
3. Kadry Z, Mc Cormack L, Clavien PA. Should living donor liver transplantation be part of every liver transplant program? J Hepatol 2005; 43: 32.
4. Busuttil RW, Tanaka K. The utility of marginal donors in liver transplantation. Liver Transpl 2003; 9: 651.
5. Clavien PA, Petrowsky H, DeOliveira ML, et al. Strategies for safer liver surgery and partial liver transplantation. N Engl J Med 2007; 356: 1545.
6. Hilden M, Christoffersen P, Juhl E, et al. Liver histology in a 'normal' population- examinations of 503 consecutive fatal traffic casualties. Scand J Gastroenterol 1977; 12: 593.
7. Underwood Ground KE. Prevalence of fatty liver in healthy male adults accidentally killed. Aviat Space Environ Med 1984; 55: 59.
8. Hornboll P, Olsen TS. Fatty changes in the liver: The relation to age, overweight and diabetes mellitus. Acta Pathol Microbiol Immunol Scand [A] 1982; 90: 199.
9. Imber CJ, St Peter SD, Lopez I, et al. Current practice regarding the use of fatty livers: A trans-Atlantic survey. Liver Transpl 2002; 8: 545.
10. Salizzoni M, Franchello A, Zamboni F, et al. Marginal grafts: Finding the correct treatment for fatty livers. Transpl Int 2003; 16: 486.
11. Boudjema K, Lindell SL, Belzer FO, et al. Effects of method of preservation on functions of livers from fed and fasted rabbits. Cryobiology 1991; 28: 227.
12. Markin RS, Wisecarver JL, Radio SJ, et al. Frozen section evaluation of donor livers before transplantation. Transplantation 1993; 56: 1403.
13. Adam R, Reynes M, Johann M, et al. The outcome of steatotic grafts in liver transplantation. Transplant Proc 1991; 23(1 Pt 2): 1538.
14. McCormack L, Petrowsky H, Jochum W, et al. Use of severely steatotic grafts in liver transplantation: A matched case-control study. Ann Surg 2007; 246: 940.
15. Verran D, Kusyk T, Painter D, et al. Clinical experience gained from the use of 120 steatotic donor livers for orthotopic liver transplantation. Liver Transpl 2003; 9: 500.
16. Burke A, Lucey MR. Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and orthotopic liver transplantation. Am J Transplant 2004; 4: 686.
17. Watt KD, Lyden ER, McCashland TM. Poor survival after liver retransplantation: Is hepatitis C to blame? Liver Transpl 2003; 9: 1019.
18. Marsman WA, Wiesner RH, Rodriguez L, et al. Use of fatty donor liver is associated with diminished early patient and graft survival. Transplantation 1996; 62: 1246.
19. D'Alessandro AM, Kalayoglu M, Sollinger HW, et al. The predictive value of donor liver biopsies on the development of primary nonfunction after orthotopic liver transplantation. Transplant Proc 1991; 23(1 Pt 2): 1536.
20. Strasberg SM, Howard TK, Molmenti EP, et al. Selecting the donor liver: Risk factors for poor function after orthotopic liver transplantation. Hepatology 1994; 20(4 Pt 1): 829.
21. Pokorny H, Langer F, Herkner H, et al. Influence of cumulative number of marginal donor criteria on primary organ dysfunction in liver recipients. Clin Transplant 2005; 19: 532.
22. Fishbein TM, Fiel MI, Emre S, et al. Use of livers with microvesicular fat safely expands the donor pool. Transplantation 1997; 64: 248.
23. Selzner M, Clavien PA. Fatty liver in liver transplantation and surgery. Semin Liver Dis 2001; 21: 105.
24. Rinella ME, Alonso E, Rao S, et al. Body mass index as a predictor of hepatic steatosis in living liver donors. Liver Transpl 2001; 7: 409.
25. Levinsky NG. Organ donation by unrelated donors.NEngl J Med 2000; 343: 430.
26. Berson A, De Beco V, Letteron P, et al. Steatohepatitis-inducing drugs cause mitochondrial dysfunction and lipid peroxidation in rat hepatocytes. Gastroenterology 1998; 114: 764.
27. Fromenty B, Pessayre D. Impaired mitochondrial function in microvesicular steatosis. Hepatology 1997; 26: 43.
28. Yoo HY, Molmenti E, Thuluvath PJ. The effect of donor body mass index on primary graft nonfunction, retransplantation rate, and early graft and patient survival after liver transplantation. Liver Transpl 2003; 9: 72.
29. Rull R, Vidal O, Momblan D, et al. Evaluation of potential liver donors: Limits imposed by donor variables in liver transplantation. Liver Transpl 2003; 9: 389.
30. Loinaz C, Gonzalez EM. Marginal donors in liver transplantation. Hepatogastroenterology 2000; 47: 256.
31. De Carlis L, Giacomoni A, Slim AO, et al. Factors involved in the functional recovery of a liver graft with particular emphasis on liver steatosis: A multivariate analysis. Transplant Proc 2001; 33: 2720.
32. Hayashi M, Fujii K, Kiuchi T, et al. Effects of fatty infiltration of the graft on the outcome of living-related liver transplantation. Transplant Proc 1999; 31: 403.
33. Wiesner RH. Patient selection in an era of donor liver shortage: current US policy. Nat Clin Pract Gastroenterol Hepatol 2005; 2: 24.
34. Mirza DF, Gunson BK, Da Silva RF, et al. Policies in Europe on "marginal quality" donor livers. Lancet 1994; 344: 1480.
35. Tullius SG, Volk HD, Neuhaus P. Transplantation of organs from marginal donors. Transplantation 2001; 72: 1341.
36. Bessems M, Doorschodt BM, van Vliet AK, et al. Improved rat liver preservation by hypothermic continuous machine perfusion using polysol, a new, enriched preservation solution. Liver Transpl 2005; 11: 539.
37. Turgeon NA, Sollinger HW, Fernandez LA, et al. Hepatic steatosis and liver transplantation. Curr Opin Organ Transplant 2004; 9: 123.